| The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer JCY Chan, DL Chan, CI Diakos, A Engel, N Pavlakis, A Gill, SJ Clarke Annals of surgery 265 (3), 539, 2017 | 291 | 2017 |
| Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance DLH Chan, N Pavlakis, GP Schembri, EJ Bernard, E Hsiao, A Hayes, ... Theranostics 7 (5), 1149, 2017 | 241 | 2017 |
| Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer DLH Chan, E Segelov, RSH Wong, A Smith, RA Herbertson, BT Li, ... Cochrane Database of Systematic Reviews, 2017 | 115 | 2017 |
| Diagnosis and management of gastrointestinal neuroendocrine tumors: an evidence-based Canadian consensus S Singh, SL Asa, C Dey, H Kennecke, D Laidley, C Law, T Asmis, D Chan, ... Cancer treatment reviews 47, 32-45, 2016 | 107 | 2016 |
| Principles of diagnosis and management of neuroendocrine tumours MJ Raphael, DL Chan, C Law, S Singh CMAJ 189 (10), E398-E404, 2017 | 105 | 2017 |
| Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors S Singh, L Moody, DL Chan, DC Metz, J Strosberg, T Asmis, DL Bailey, ... JAMA oncology 4 (11), 1597-1604, 2018 | 85 | 2018 |
| Prognostic and predictive biomarkers in neuroendocrine tumours DL Chan, SJ Clarke, CI Diakos, PJ Roach, DL Bailey, S Singh, N Pavlakis Critical reviews in oncology/hematology 113, 268-282, 2017 | 65 | 2017 |
| Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors S Singh, DL Chan, L Moody, N Liu, HD Fischer, PC Austin, E Segelov JAMA oncology 4 (4), 583-585, 2018 | 63 | 2018 |
| Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis KP Willowson, AR Hayes, DLH Chan, M Tapner, EJ Bernard, R Maher, ... EJNMMI research 7 (1), 46, 2017 | 55 | 2017 |
| Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer J Jee, ES Lebow, R Yeh, JP Das, A Namakydoust, PK Paik, JE Chaft, ... Nature Medicine, 1-11, 2022 | 53 | 2022 |
| Everolimus in the management of metastatic neuroendocrine tumours DL Chan, E Segelov, S Singh Therapeutic advances in gastroenterology 10 (1), 132-141, 2017 | 41 | 2017 |
| The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials E Segelov, D Chan, J Shapiro, TJ Price, CS Karapetis, NC Tebbutt, ... British journal of cancer 111 (6), 1122, 2014 | 38 | 2014 |
| A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement JCY Chan, CI Diakos, DLH Chan, A Engel, N Pavlakis, A Gill, SJ Clarke Annals of surgery 267 (6), 1119-1125, 2018 | 37 | 2018 |
| Anti‐epidermal growth factor receptor therapy for glioblastoma in adults A Lee, M Arasaratnam, DLH Chan, M Khasraw, VM Howell, H Wheeler, ... Cochrane Database of Systematic Reviews, 2019 | 36 | 2019 |
| Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review DL Chan, D Ferone, M Albertelli, N Pavlakis, E Segelov, S Singh Endocrine 57 (3), 366-375, 2017 | 36 | 2017 |
| Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature DL Chan, N Pavlakis, J Shapiro, TJ Price, CS Karapetis, NC Tebbutt, ... PloS one 10 (8), e0135599, 2015 | 34 | 2015 |
| PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer AM Taylor, DLH Chan, M Tio, SM Patil, TA Traina, ME Robson, ... Cochrane Database of Systematic Reviews, 2021 | 32 | 2021 |
| In vivo quantification of 177 Lu with planar whole-body and SPECT/CT gamma camera imaging DL Bailey, TM Hennessy, KP Willowson, EC Henry, DLH Chan, A Aslani, ... EJNMMI physics 2 (1), 20, 2015 | 32 | 2015 |
| External Beam Radiotherapy in the Treatment of Gastroenteropancreatic Neuroendocrine Tumours: A Systematic Review DL Chan, R Thompson, M Lam, N Pavlakis, J Hallet, C Law, S Singh, ... Clinical Oncology 30 (7), 400-408, 2018 | 30 | 2018 |
| Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors W Chi, RRP Warner, DL Chan, S Singh, E Segelov, J Strosberg, ... Pancreas 47 (3), 321-325, 2018 | 29 | 2018 |
